These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3934385)

  • 1. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
    Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
    J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the inhibition of methotrexate-sensitive and -resistant Lactobacillus casei cell cultures with purified Lactobacillus casei dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-substituted-phenyl)-s-triazines. Use of quantitative structure-activity relationships in making inferences about the mechanism of resistance and the structure of the enzyme is situ compared with the enzyme in vitro.
    Coats EA; Genther CS; Dietrich SW; Guo ZR; Hansch C
    J Med Chem; 1981 Dec; 24(12):1422-9. PubMed ID: 6796688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative structure-activity relationships of antifolate triazines inhibiting murine tumor cells sensitive and resistant to methotrexate.
    Selassie CD; Hansch C; Khwaja TA; Dias CB; Pentecost S
    J Med Chem; 1984 Mar; 27(3):347-57. PubMed ID: 6699880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the inhibition of growth of methotrexate-resistant and -sensitive leukemia cells in culture by triazines. Evidence for a new mechanism of cell resistance to methotrexate.
    Selassie CD; Guo Z; Hansch C; Khwaja TA; Pentecost S
    J Med Chem; 1982 Feb; 25(2):157-61. PubMed ID: 7057421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of triazines as inhibitors of L1210 dihydrofolate reductase and of L1210 cells sensitive and resistant to methotrexate.
    Selassie CD; Strong CD; Hansch C; Delcamp TJ; Freisheim JH; Khwaja TA
    Cancer Res; 1986 Feb; 46(2):744-56. PubMed ID: 3940640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confirmation of collateal sensitivity to pyrimethamine in Lactobacillus casei ATCC 7469 resistant to chlorguanide triazine.
    Smith CC; Genther CS
    Ann N Y Acad Sci; 1971 Nov; 186():185-6. PubMed ID: 5002297
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of dihydrofolate reductase and cell growth by antifolates in a methotrexate-resistant cell line.
    Hamrell MR
    Oncology; 1984; 41(5):343-8. PubMed ID: 6540852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of dihydrofolate reductase and thymidylate synthetase in strains of Streptococcus faecium resistant to substituted pyrimidines, triazines and MTX.
    Smith CC; Freisheim JH
    Ann N Y Acad Sci; 1971 Nov; 186():182-4. PubMed ID: 5002296
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyrimethamin-resistant Plasmodium falciparum lack cross-resistance to methotrexate and 2,4-diamino-5-(substituted benzyl) pyrimidines.
    Walter RD; Bergmann B; Kansy M; Wiese M; Seydel JK
    Parasitol Res; 1991; 77(4):346-50. PubMed ID: 1866423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s. A quantitative structure-activity relationship analysis.
    Hathaway BA; Guo ZR; Hansch C; Delcamp TJ; Susten SS; Freisheim JH
    J Med Chem; 1984 Feb; 27(2):144-9. PubMed ID: 6694162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
    Hansch C; Li R; Blaney JM; Langridge R
    J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
    Selassie CD; Fang ZX; Li RL; Hansch C; Debnath G; Klein TE; Langridge R; Kaufman BT
    J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
    Genther CS; Smith CS
    J Med Chem; 1977 Feb; 20(2):237-43. PubMed ID: 137981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase.
    Duch DS; Edelstein MP; Bowers SW; Nichol CA
    Cancer Res; 1982 Oct; 42(10):3987-94. PubMed ID: 6955006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s.
    Hansch C; Hathaway BA; Guo ZR; Selassie CD; Dietrich SW; Blaney JM; Langridge R; Volz KW; Kaufman BT
    J Med Chem; 1984 Feb; 27(2):129-43. PubMed ID: 6420569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
    Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
    J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
    Selassie CD; Li RL; Poe M; Hansch C
    J Med Chem; 1991 Jan; 34(1):46-54. PubMed ID: 1899453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.